Octreotide for Injectable Suspension

Generic name

octreotide (as acetate)

Brand Reference

Sandostatin LAR®

Therapeutic Class

Synthetic octapeptide analogue of somatostatin

Strength

30 mg

DIN

02503786

Product form

Powder for Suspension (Sustained Release)


PowderForSuspension

Product Details

Product Code

UPC

Pack Size

65411-0001 068510998484 Vial 1

Ingredients

Please view the product monograph to find details of all ingredients contained in this product.  For additional generic & OTC product inquiries, please call 1-800-268-4127, option 3 or email druginfo@tevacanada.com.


Storage

Store between 2°C - 8°C. Keep vial in the outer carton in order to protect it from light. The vials can remain at room temperature on the day of the injection. However the suspension must only be prepared immediately prior to intramuscular (i.m.) injection. Store the pre-filled syringe with 2 mL diluent at 2°C - 8°C. Do not freeze.


Information

All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.

"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves